Fluorescent labeling of proteins by genetically encoded fluorescent protein tags has enabled an enhanced understanding of cell biological processes but is restricted to the analysis of a limited number of identified proteins. This approach does not permit, e.g., the unbiased visualization of a full proteome in situ. We describe here a fluorescencebased method to follow proteome-wide patterns of newly synthesized proteins in cultured cells, tissue slices, and a whole organism. This technique is compatible with immunohistochemistry and in situ hybridization. Key to this method is the introduction of a small bio-orthogonal reactive group by metabolic labeling. This is accomplished by replacing the amino acid methionine by the azide-bearing methionine surrogate azidohomoalanine (AHA) in a step very similar to classical radioisotope labeling. Subsequently, an alkyne-bearing fluorophore is covalently attached to the group by "click chemistry"-a copper(I)-catalyzed [3+2]azide-alkyne cycloaddition. By similar means, metabolic labeling can also be performed with the alkyne-bearing homopropargylglycine (HPG) and clicked to an azide-functionalized fluorophore.
INTRODUCTION
This unit describes fluorescent noncanonical amino acid tagging (FUNCAT), a recently developed fluorescent labeling method to visualize proteome-wide spatio-temporal patterns of newly synthesized proteins (Beatty and Tirrell, 2008; Roche et al., 2009; Dieterich et al., 2010; Tcherkezian et al., 2010; Hinz et al., 2012) . This method complements its nonfluorescent sister technology BONCAT (bio-orthogonal noncanonical amino acid tagging) that enables the tagging of newly synthesized proteins for selective isolation and identification (Dieterich et al., 2006 ; for detailed BONCAT protocol see Dieterich et al., 2007) .
FUNCAT is based on the introduction of small bio-orthogonal, chemically reactive alkyne or azide groups into proteins by means of metabolic labeling with the noncanonical amino acid analogs azidohomoalanine (AHA, azide-bearing) or homopropargylglycine (HPG, alkyne-bearing) . Both amino acid analogs are surrogates for methionine and are incorporated into nascent proteins when applied to the extracellular medium and taken up by the cells (Dieterich et al., 2006) . Thus, the metabolic labeling step is very similar to classical radioisotope labeling and can be combined with or follow drug treatment
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Current Protocols in Cell Biology or electrophysiological stimulation (Fig. 7.11.1) . To increase the fraction of replaced methionine, a methionine depletion step prior to AHA or HPG addition is advisable, and methionine must be absent from the medium during the metabolic labeling reaction. The incorporated azide or alkyne groups, as nonbiological reactive "handles," serve to distinguish newly synthesized proteins from the pre-existing protein fraction before metabolic labeling. Following AHA (or HPG) treatment cells are fixed and a fluorophore is covalently and chemoselectively attached to the introduced functional groups by means of "click chemistry"-a copper(I)-catalyzed [3+2]azide-alkyne cycloaddition (for details and chemistry see Background Information).
The decision about which tissue or cell line to use, which protocol, and the exact conditions to carry out the FUNCAT labeling obviously depends on the biological question of interest. In the protocols provided we give recommendations for appropriate concentrations and incubation times to use-these serve as good starting points as these conditions typically yield robust labeling. In the protocols we indicate the importance of the biological question and discuss several parameters to consider. We also discuss the limitations of this method in the Commentary. Figure 7 .11.1 gives an overview of the protocols and shows additional options for further extending experiments (e.g., to live imaging studies).
BASIC PROTOCOL
FUNCAT IN CELL LINES AND PRIMARY CELLS
This protocol describes the metabolic labeling of cultured standard cell lines or cultured primary cells with the azide-bearing noncanonical amino acid azidohomoalanine (AHA) or alternatively the alkyne-bearing amino acid homopropargylglycine (HPG) and the subsequent visualization of labeled proteins using chemoselective fluorescence tagging based on click-chemistry. It is applicable for the examination of new protein synthesis on a cellular level within a specified time frame and specified conditions. Since the fluorescence tagging procedure is performed with fixed and permeabilized cells, newly synthesized proteins of all cell compartments can be visualized.
The protocol is divided into three parts including the metabolic labeling of cells, the FUNCAT-reaction allowing visualization of labeled proteins, and an optional additional immunocytochemistry procedure. Included are basic recommendations and relevant observations for the procedure. This procedure is easy to perform and allows robust and reproducible results in a time frame of about two days.
Materials
Adherent cells from primary cell preparation or cell lines grown on: 18-mm glass coverslips in a 12-well culture plate or 12-mm glass coverslips in a 24-well culture plate or MatTek glass-bottom dishes Methionine-free media [e.g., HBS (see recipe) or methionine-free DMEM with supplements (see recipe) or methionine-free Hibernate A with B27 (see recipe)] (C) Standard microfluidic chamber for compartmentalized neuron incubation. Neurons are plated on the cell body chamber side through the connected wells 1. They extend axons and dendrites into the microgrooves but only axons grow the whole 900-μm distance through the microgrooves and reach the axon chamber that is accessible via the connected wells 2. Dendrites usually stop growing at a 200-to 300-μm distance within the microgrooves. The cell body and axon chamber can be fluidically isolated; therefore, compartments can be incubated with different solutions.
(D) The microfluidic local perfusion (μLP) version of the microfluidic chamber has a perfusion channel perpendicular to the microgrooves (Taylor et al., 2010) . It is located at a distance from the cell body chamber where dendrites still populate the microgrooves. Thus, perfusion via the perfusion channel allows one to manipulate selectively a proportion of dendrites and axons. (E) The microfluidic chambers are assembled on coverslips where the cells attach. After metabolic labeling, the PDMS part of the chamber is removed and the cells are fixed and processed further on the coverslip. Upside-down incubation for the click reaction is performed on Parafilm with unilateral silicone spacer support in a humidified chamber. 3. Dilute AHA from the stock solution to a final concentration of 4 mM AHA in methionine-free medium and add any other desired stimulus/drug. Incubate the cells for 2 hr (or any other appropriate time) using culture conditions according to the cell type. To evaluate background labeling, treat control cells with 4 mM methionine and/or 4 mM AHA in presence of a protein synthesis inhibitor (e.g., 40 μM anisomycin).
Protein
AHA is relatively expensive but can easily be synthesized 10. Assemble the FUNCAT reaction protected from light (e.g., cover with a box or aluminum foil) and without interruption at room temperature in the following order: a. 5 ml PBS, pH 7.8. c. Add 5 μl of 500 mM TCEP stock solution (1:1000) and vortex at high speed for 10 sec. d. Add 0.5 μl to 1 μl of 2 mM fluorophore-alkyne-tag (1:5000 to 1:10,000) and vortex at high speed for 10 sec. 
FUNCAT IN HIPPOCAMPAL SLICES
FUNCAT labeling is applicable to intact tissues such as acute hippocampal slices. This protocol summarizes steps for fluorescence detection of proteins in acute hippocampal slices that are newly synthesized during an incubation period of up to several hours after dissection. This protocol uses AHA metabolic labeling and immunohistochemistry in acute hippocampal slices and is accomplished within 3 days. The same protocol can be used to label organotypic slice cultures.
Materials
Acute 450 
Wash once with PBS-MC.
Use enough PBS-MC to cover the sections.
4. Fix with PFA-sucrose for 20 min at room temperature.
The horizontal shaker is used in all subsequent incubation and washing steps.
Use enough PFA-sucrose to cover the sections.
Wash once with PBS-MC.
6. Embed the fixed slices in 3% agarose. 10. Transfer the re-sectioned slices into 24-well plates filled with PBS, pH 7.8.
11. Permeabilize the slices with 0.5% Triton X-100 in B-Block overnight at room temperature. 
Perform chemo-selective fluorescence tagging
Day 2 12. Wash the slices three times, each time with 0.1% Triton X-100 in PBS (PBS-Tx), pH 7.8
13. Assemble the FUNCAT reaction, protected from light, without interruption in the following order in a 15-ml Falcon tube:
a. 5 ml PBS, pH 7.8. b. Add 5 μl of 200 mM TBTA stock solution (1:1000) and vortex at high speed for 10 sec.
After addition of TBTA the solution will turn milky.
c. Add 5 μl of 500 mM TCEP stock solution (1:1000) and vortex at high speed for 10 sec. d. Add 5 μl of 2 mM fluorophore-alkyne-tag (1:1000) and vortex at high speed for 10 sec. 
FUNCAT IN LARVAL ZEBRAFISH
Metabolic labeling with AHA to visualize areas of new protein synthesis is also applicable to the larval zebrafish. Nacre zebrafish lack melanophores and, therefore, enable direct imaging e.g., of the nervous system without prior dissection. AHA has been found not to be toxic to the live organism at the concentration described here (Hinz et al., 2012) ; however, longer incubations than compared to cell culture and hippocampal slices are necessary to allow for diffusion of AHA into the tissue and incorporation into newly synthesized proteins. High levels of fluorescence have been found especially in the tail muscles and the liver; however, visualization of differential protein synthesis was also possible in the spinal cord and nervous system. This protocol is accomplished within ∼1 week. Day 2 2. Wash the larval zebrafish three times, each time for 5 min with 10 ml E3 embryo medium at room temperature.
Materials
3. Transfer the larvae into a 1.5-ml microcentrifuge tube and anesthetize for 30 min to 1 hr on ice.
Do not use more than ∼5 larvae in each tube.
4. Remove the remaining E3 embryo medium and replace with 500 μl room temperature PFA-sucrose fixative. Incubate for 3 hr at room temperature and invert the tube every 30 min.
5. Wash the larval zebrafish briefly in 100% methanol at room temperature.
6. Incubate in 500 μl of 100% methanol overnight at −20 • C.
At this step, samples can be stored for prolonged time periods.
Perform chemo-selective fluorescence tagging
Day 3 7. Rehydrate the larvae by successive 5-min washes in 75% methanol in PBS-T, 50% methanol in PBS-T, 25% methanol in PBS-T, and PBS-T, pH 7.4.
8. Wash twice, each time for 5 min with 500 μl PBDTT at room temperature.
9. Permeabilize the sample by incubating in 500 μl of 10 μg/ml Proteinase K in PBS-T, pH 7.4, for 1 hr at room temperature.
Do not exceed 1 hr incubation, as tissue will deteriorate rapidly.
10. Wash briefly in 500 μl PBS-T, pH 7.4, and immediately post-fix for 20 min in 500 μl PFA-sucrose at room temperature.
11. Wash twice, each time with 500 μl PBS-T, pH 7.4.
12. Wash three times, each time with 500 μl PBDTT for 5 min.
13. Incubate in 500 μl Z-Block for 3 hr at 4 • C.
14. Wash three times, each time with 500 μl PBS-T, pH 7.8, for 10 to 15 min at room temperature.
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15. Assemble the FUNCAT reaction mix, protected from light, without interruption in the following order in a 1.5-ml microcentrifuge tube:
a. 1 ml PBS-T, pH 7.8. c. Add 1 μl of 500 mM TCEP stock solution (1:1000) and vortex at high speed for 10 sec. d. Add 2.5 μl of 2 mM fluorophore-alkyne-tag (1:400) and vortex at high speed for 10 sec. 16. Incubate each set of five larvae in 0.5 ml FUNCAT reaction mix overnight at room temperature with agitation.
Immunohistochemistry
Day 4
17. Wash four times, each time with 500 μl PBDTT + 0.5 mM EDTA for 30 min at room temperature. 
Day 6
21. Wash twice, each time with 500 μl PBDTT for 1 hr at room temperature.
22. Wash four times, each time with 500 μl PBDTT for 30 min at room temperature.
23. Wash with 500 μl PBS, pH 7.4, for 15 min at room temperature.
24. Prepare a 0.6% agarose solution in E3 embryo medium, heating the solution in the microwave to dissolve the agarose. Let cool slightly. Mount the samples in 0.6% agarose on MatTek dishes, using a stereomicroscope to position and orient the samples.
When mounting larvae, place the area of interest directly against the glass area of the MatTek dish.
ALTERNATE PROTOCOL 3
FUNCAT IN MICROFLUIDIC CHAMBERS
In order to approach visualization of newly synthesized proteins in combination with either compartmentalized labeling or compartment specific treatment of neurons, we use FUNCAT in microfluidic chamber devices (Taylor et al., 2010 Microfluidic chambers (Taylor et al., 2010; Fig. 7 .11.2C,D; available from Xona Microfluidics LLC: SDN900 or μLP) Syringe pump 37
• C incubator Spacer (approximately 3 × 1 × 1-mm 3 ) Humidified chamber
Metabolic labeling of newly synthesized proteins in microfluidic chambers
Day 1
1. Wash the cell body chamber two times with 300 μl prewarmed methionine-free Hibernate A.
Aspirate medium from both connected cell body wells (wells 1 in Fig. 7 2. Wash the axon chamber twice, each time with 300 μl prewarmed methionine-free Hibernate A.
3. Replace the medium in all perfusion channel wells with 75 μl prewarmed (37 • C) methionine-free Hibernate A.
4. Connect syringe pump tubing to the channel outlet. Set the pump to withdrawal mode with 0.1 ml/hr. Taylor et al., 2010 7. Incubate for the desired time (starting point 2 hr) with chambers placed in the incubator with constant pumping and perfusion.
Adjust time and drug/AHA concentrations according to the biological question.
8. Place the dishes on ice and gently remove the PDMS part of the chamber without displacing dendrites (Fig. 7 .11.2E).
9. Wash the coverslips immediately two times, each time with 1 ml ice-cold PBS-MC.
10. Wash once with 0.5 ml fixation solution, and then fix for 20 min at room temperature with 0.5 ml PFA-sucrose or PLP.
11. Wash once with 0.5 ml PBS-Tx and then permeabilize with 0.5 ml PBS-Tx for 15 min at room temperature.
If preferentially newly synthesized membrane proteins are intended to be labeled, this step can be omitted. Note that this significantly reduces the signal obtained later. For this purpose, blocking buffer in the next step has to be without detergent and cells have to be permeabilized with PBS-Tx and blocked before immunocytochemistry and after FUNCAT reaction.
Chemo-selective fluorescence tagging 12. Incubate in 0.5 ml C-Block for 1 hr at room temperature.
13. Wash twice, each time for 5 min with 1 ml PBS, pH 7.8.
14. Prepare 1 ml FUNCAT reaction mix per coverslip as described in the Basic Protocol (step 10a-d).
15. Incubate the coverslip upside down in the click reaction mix overnight at room temperature. (Fig. 7.11 
Pipet 1 ml FUNCAT reaction mix on Parafilm in a humidified chamber, position a small spacer (made from silicone or any other inert material) next to the drop and place the coverslip upside down with one edge on the Parafilm and one resting on the spacer
SUPPORT PROTOCOL
COMBINATION OF FUNCAT WITH HIGH-RESOLUTION FISH
This protocol describes the steps necessary to combine FUNCAT with high-resolution fluorescence in situ hybridization using the Affymetrix QG ViewRNA method based on branched DNA in situ hybridization (Player et al., 2001 ). 6. Wash three times, each time with PBS at room temperature.
Additional Materials (also see Basic Protocol and Alternate Protocol 3)
The manufacturer recommends a proteinase K digestion step that is not performed in this protocol to avoid degradation of the newly synthesized proteins.
7. Equilibrate in 150 μl working protease stop buffer up to 30 min until the probe set is prepared at room temperature. 10. Wash three times, each time with RNAView wash buffer at room temperature.
11. Optional: Store in working storage buffer overnight at 4 • C.
Day 2
Amplify hybridized probe set 12. Wash twice, each time with RNAView wash buffer at room temperature.
13. Incubate with PreAmp mixture 1 hr at 40 • C in a humidified chamber in the hybridization oven.
Dilute PreAmp 1:100 in working amplifier diluent prewarmed to 40
• C in the thermomixer heat block.
14. Wash three times, each time with RNAView wash buffer at room temperature. 
Agarose solution
Dissolve low-gelling temperature agarose in 1× PBS, pH 7.8, to a final concentration of 3% by heating on a hot plate magnetic stirrer. Prepare fresh.
AHA or HPG or methionine
Dissolve AHA (L-azidohomoalanine, Invitrogen) or HPG (L-homopropargylglycine, Invitrogen) or methionine in 1× HBS or in methionine-free medium to a final concentration of 100 mM. Store up to 1 week at 4 • C.
Anisomycin stock solution
Dilute anisomycin (Tocris) to a final concentration of 40 mM in DMSO. Divide into 10-μl aliquots. Store aliquots up to 1 month at −20 • C.
B-Block
Dissolve the following in 1× PBS, pH 7.4: 10% normal horse serum 5% sucrose 2% bovine serum albumin ( 
FUNCAT incubation plate
To prepare FUNCAT incubation plates use a 12-well or 24-well culture plate according to the coverslip size used. Heat paraffin (e.g., Granopent "P", Carl Roth) in a glass beaker on a hot plate with a temperature of 150 • C. Dip a glass pipet into the fluid paraffin and make four paraffin dots of the size of a pin per well. The plates can be cleaned easily and reused many times (Fig. 7.11.2A ).
FUNCAT-wash buffer
Dissolve in PBS, pH 7.8 0.5 mM EDTA 1% Tween-20
HBS, 2×
238 mM NaCl 10 mM KCl 
MatTek overhead incubation support
Fill the lid of a 5-ml round-bottom tube with toy modeling clay. Leave a 2-to 3-mm space to the edge and seal the surface with a layer made from two-component epoxy glue. The created well should hold 300 μl solution (Fig,. 7 .11.2B).
Methionine-free medium
For DMEM minus methionine, minus cysteine, minus glutamine, add L-cysteine to a final concentration of 0.201 mM, add glutamine, serum and other supplements necessary for cultivation of cell culture lines. Filter through 0.22-μm pore size sterile filters. For methionine-free Hibernate A, add supplements necessary for cultivation of primary cell cultures. The use of B27 (Invitrogen, 1:50) for cultivation of neuronal cultures is advisable. Filter through 0.22-μm pore size sterile filters.
1× PB, pH 7.4
21.71 g Na 2 HPO 4 ·7 H 2 O 2.62 g NaH 2 PO 4 ·H 2 O Adjust volume to 1 liter with distilled water Store up to 6 months at 4
• C
PBS-DTT
Dissolve 1% dimethyl sulfoxide (DMSO), 0.5% Triton X-100, and 0.1% Tween-20 in 1× PBS, pH 7. 
PBS-T
Dissolve 0.1% Tween-20 in 1× PBS Adjust pH to 7.4 or 7.8 with a few drops of 1 N NaOH Prepare fresh
PBS-Tx
Dissolve 0.1% Triton X-100 in 1× PBS Prepare fresh 
PFA-Sucrose
PBS-MC
Puromycin (1000× stock)
Dissolve 5 mg/ml puromycin in distilled water Divide into 10-to 25-μl aliquots 
TBTA
Dissolve TBTA {Tris [(1-benzyl-1H-1,2,3-triazol-4-yl) methyl]amine} in anhydrous, freshly opened dimethyl sulfoxide (DMSO) to a final concentration of 200 mM Divide into 10-or 20-μl aliquots Store aliquots up to 6 month at −20
Avoid repeated freezing and thawing of aliquots (no more than 3 times).
TCEP
Dissolve TCEP-HCl [Tris-(2-carboxyethyl)phosphine hydrochloride] to a final concentration of 500 mM in distilled water
Prepare solution fresh directly before use
Z-Block
Dissolve in PBDTT:
5% BSA 10% normal goat serum Filter through 0.22-μm pore size sterile filters Store up to 1 year at −20 • C
COMMENTARY Background Information
Comparison with other methods Fluorescent labeling of proteins by genetically encoded fluorescent protein tags pioneered by GFP opened a new era in understanding cell biological processes by visualization of spatio-temporal patterns in protein distribution (Chalfie et al., 1994; Heim et al., 1994) . One drawback of this approach is the relatively big size of the tag, which in some cases affects the folding and behavior of the proteins of interest. Another limitation became obvious with the focus of studies turning to a systems biological point of view. With the genetically encoded fluorescent tagging approach the analysis is restricted to a limited number of known proteins at a given time.
Metabolic labeling of the proteome with either radioisotope-or stable isotope-tagged amino acids are powerful methods to quantify or identify and compare proteome-wide changes in combination with biochemistry and mass spectrometry, respectively (Hu et al., 2004; Cox and Mann, 2011 processes, it is perfectly suited to reflect physiological conditions. In contrast, these methods are not well-suited for either the purification of the newly synthesized protein pool or the in situ visualization within the cell. The conversion of radioactivity into a visual signal by exposure to film emulsion is timeconsuming and difficult to combine with other imaging methods, and cannot be extended to live imaging. BONCAT and FUNCAT fill these gaps. FUNCAT is a fluorescence-based method to follow proteome-wide patterns of newly synthesized proteins in situ and is compatible with immunohistochemistry and in situ hybridization. Introduction of noncanonical amino acids with small, bioorthogonal chemical handles enables a multitude of ligation options (Fig. 7.11.3 A,B) , e.g., to fluorophores for visualization (FUNCAT), biotin for purification and mass spectrometry (BONCAT), but is not limited to those. Thus, the elegance in this approach lies in the versatility of the method.
Mechanism and chemistry
As described above, the introduction of a small bio-orthogonal reactive handle is accomplished by metabolic labeling similar to classical radioisotope labeling. Methionine is replaced in the medium by the azide-or alkyne-bearing methionine surrogates AHA or HPG (Fig. 7.11.3A) . Both noncanonical amino acids are taken up by cellular amino acid transporters-mainly by LAT1 (Fig. 7.11.3C ; Kanai et al., 1998) . Key to this methodology is that not only transporters but also endogenous methionyl tRNA synthetase (MetRS)-the enzyme charging methionine onto its tRNAaccepts AHA and HPG as substrates, although with lower efficiency than methionine (Kiick et al., 2002) . Once charged onto the tRNA, incorporation of the amino acid analogs into nascent proteins is straightforward. Thus, during metabolic labeling newly synthesized proteins are endowed with new functionalities, namely azide (AHA) or alkyne (HPG) groups that differentiate them from the pre-existing protein pool (Fig. 7.11.3C ). If AHA and HPG are applied sequentially (or potentially also at two distinct places), two different subpopulations of proteins are labeled .
After incorporation into newly synthesized proteins, the functional groups are visualized by fluorophores in a reaction based on "click chemistry"-a copper(I)-catalyzed [3+2]azide-alkyne cycloaddition (Fig. 7.11 .3B,C; Rostovtsev et al., 2002; Tornoe et al., 2002) . To this end, the fluorophore has to be functionalized by the respective counterpart. AHA reacts with alkyne-bearing fluorescent tags; HPG is clicked to azide carriers. The catalyzing Cu(I) is produced directly in the reaction from TCEP and Cu(II) and the triazole ligand TBTA serves the dual purpose of both activating the Cu(I) ion for catalysis and protecting it from disproportionation, thus improving the kinetics of the bioconjugation and also allowing for long reaction times required in some protocols (for further details see Prescher and Bertozzi, 2005; Dieterich and Link, 2009; Dieterich, 2010) .
Limitations and extensions
Beside the versatility of the method in general, the introduction of bioorthogonal groups by AHA and HPG have the advantage of minimal interference with protein folding, trafficking and function (Dieterich et al., 2006) due to the small-size chemical tags and, thus, the likely close reflection of physiological conditions. The conditions given in the protocols give robust labeling .5) but may need adaptation to an individual cell type or a particular question-see the Critical Parameters and Troubleshooting section.
A prerequisite for a protein to be labeled by this method is the presence of at least one naturally occurring methionine in the protein, and, secondly, that this be replaced by the surrogate amino acid during protein synthesis. Even if the number of potential replacement sites is not a severe limitation since e.g., for the zebrafish genome a fraction of 99.99% percent of proteins was calculated to fulfill this prerequisite and 99.98% of all protein entries of a human protein database contain at least a single methionine (Dieterich et al., 2006; Hinz et al., 2012) , the replacement fraction sometimes is. The factors most prominently influencing the fraction of methionine replacement are the competition with the internal methionine pool and the incubation time. With long incubation periods, eventually a steady state level will be reached, but never full replacement. The shorter the metabolic labeling time the more important it will be to reduce competition by methionine. Methionine depletion prior to the AHA metabolic labeling decreases competition by methionine for charging onto its tRNA, but also provides a nonphysiological situation to the cell. Long metabolic labeling times might become an issue when cells, in particular neurons, do not tolerate or react to long incubations in artificial medium or when intended local applications are counteracted by intracellular distribution or diffusion of the amino acids or drugs. In microfluidic
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Supplement 56 Current Protocols in Cell Biology chambers we have found that after 1 hrregardless from which compartment AHA is loaded-the noncanonical amino acid reached the cell body even when fluidic isolation is intact (Fig. 7.11 .5B,C). The advantage that FUNCAT labels newly synthesized proteins on a proteome-wide level might turn into a disadvantage when, for instance, only a subpopulation of cells is of interest and the signal in other cell types creates a "background." New developments aim to restrict the metabolic labeling. Expression of mutant MetRS versions that accept a longer-chain homolog of AHA-ANL (azidonorleucine)-that in turn is not a substrate of the endogenous MetRS, are a potential way to genetically control the metabolic labeling (Ngo et al., 2009) . Genetic manipulation of the MetRS instead of the protein of interest directly, as in fluorescent protein-tagged approaches, rules out problems and restrictions due to overexpression and the limited capacity for genetically encoding several tags at the same time.
The fact that CuSO 4 is toxic to cells limits the use of the protocols described here to manipulations that are analyzed after fixation of the cells or tissue of interest. Recent developments to apply this technique also in live cells make use of the fact that [3+2]azide-alkyne cycloaddition not only can be catalyzed by Cu(I) but also is achieved by strain promotion (Agard et al., 2004) . The embedding of the alkyne moiety into a cyclooctene structure with sidechains that promote strain as in DIBO (dibenzocyclooctyne) or DIFO (difluorinated cyclooctyne) thus enables a copper-free click reaction. To date, the poor membrane permeability of the reagents limit the application to labeling of newly synthesized membrane proteins , but efforts are in progress to extend the repertoire of reagents to enable the live visualization of intracellular proteins (Beatty et al., 2010 (Beatty et al., , 2011 .
Critical Parameters & Troubleshooting
The conditions given in the protocols should lead to robust labeling . Problems that could arise and their possible solutions are listed in Table 7 .11.1. However, the starting times and concentrations suggested here might not be optimal for all biological questions. Adaptations of parameters in the protocol should consider the following: protein synthesis rates differ between cell types. Incorporation of the amino acid surrogates into post-mitotic cells, like neurons, is lower than in dividing cells. The choice of the labeling medium should also be considered. The ideal labeling medium with respect to cell health and physiological state would be the respective fully complemented and conditioned culturing medium free of methionine. Unfortunately, this is not possible in most cases. While cell lines usually tolerate an incubation in 1× HBS or unsupplemented media well, this is certainly not the case for neurons. We use methionine-free Hibernate A supplemented with B27 for neurons and found that leaving out B27 already for short incubations compromises the neurons. We recommend to test if cells tolerate the incubation conditions of choice before performing a metabolic labeling experiment.
When adjusting the incubation conditions for FUNCAT experiments in microfluidic chambers, factors that might be critical and have to be controlled for are, e.g., extracellular and intracellular diffusion of drugs or amino 
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Current Protocols in Cell Biology Supplement 56 Background from FUNCAT signal Change the combination of fluorophores for FISH and fluorescent tag acid analogs, uptake capacity of the respective cellular compartment for AHA (neurites of different neuron types might have different amino acid transporter densities), and the time needed for newly synthesized proteins to reach their final destination. From our experience, it is crucial to control every microfluidic chamber for the quality of the cultured neurons and ensure that dendrites and axons populate the microgrooves evenly without any cell debris clogging the microgrooves. When combining this protocol with FISH, any source of RNase contamination should be avoided after the fixation step. Click reaction time, blocking steps, and antibody incubation steps can be shortened. Of note, we do not use proteinase K treatment in this FISH protocol (in contrast to the manufacturer's recommendation). We avoid proteinase K in order to preserve the integrity of newly synthesized proteins and enable the combination with immunocytochemistry. The procedure leads to clear and highly localized in situ signals with every antisense probe set we used so far.
Anticipated Results
Application of the protocols should result in fluorescent labeling of cells and tissue that is clearly distinguishable from background labeling as assessed with a methionineincubated control or when compared to a sample treated with AHA in the presence of a protein synthesis inhibitor. Typical example results with immunostaining are shown in Figures 7.11.4 and 7.11.5. In our experience, we face detection limits in hippocampal neurons when we lower concentrations of AHA to less than 100 μM or limit incubation times to <10 min. These limits depend on the cell types used and should be analyzed by comparison with the respective controls.
Time Considerations
The Basic Protocol is usually accomplished within 2 days. One day is needed for metabolic labeling, with the exact length depending on the incubation time. Fixation, blocking, and preparation for the FUNCAT reaction need approximately 2 hr. The click reaction itself is carried out overnight but can-with concomitant loss of signal intensity-be shortened to few hours. The next day, optional immunocytochemistry requires an additional ∼5 hr. If FISH (Support Protocol) is included in the procedure, the first day includes, after metabolic labeling, (depending on desired time), fixation, and permeabilization (approximately 1 hr in total), a 3 hr probe set hybridization. Next, the protocol has an overnight storage step that can be omitted. The remainder of the FISH protocol is accomplished in 4 hr (3 hr of them incubation time) before switching back to the FUNCAT basic protocol (FUNCAT reaction mix incubation).
Alternate Protocol 1 (FUNCAT in hippocampal slices) is carried out within 3 days. The most time-consuming part compared to the other protocols is the re-sectioning of the agarose-embedded slices on day 1, which takes ∼1 hr per slice.
Alternate Protocol 2 (FUNCAT in larval zebrafish) needs longer incubations to ensure penetration of reagents into the whole organism. The whole protocol from metabolic labeling to immunohistochemistry takes one week.
Alternate Protocol 3 (FUNCAT in microfluidic chambers) is comparable in time to the Basic Protocol.
